Advances in Heart Failure - Is It Time to Redefine Patient Selection for Sodium-Glucose Co-transporter 2 Inhibitors?
Published: 09 October 2020
-
Views:
61
-
Likes:
7
-
Views:
61
-
Likes:
7
Overview
This educational symposium was originally broadcast as part of the ESC 2020 Digital Congress.
The programme focuses on summarising recent data on SGLT2 inhibitors showing reductions in CV risk, HF hospitalisations and mortality, as well as improved quality-of-life. The expert panel also discuss how these agents should be introduced into clinical practice and contemporary heart failure guidelines for both diabetics and non-diabetics.
Learning Objectives
- Discuss Current SGLT2 Data and Guideline Recommendations for Utilization in Heart Failure
- Evaluate Emerging Data on the Treatment of Heart Failure with SGLT2 Inhibitors
- Understand the Implications of Emerging Data on the Treatment of Heart Failure With SGLT2 Inhibitors
More from this programme
Part 1
SGLT2s as a Heart Failure Drug – How Did We Get Here?
Part 2
Emerging Data SGLT2 Inhibitors in Heart Failure
Part 3
Guidelines and Practice Implications
Part 4
Q&A Discussion
| 1 session | |
| Q&A Discussion | Watch now |
Part 5
Follow-up Peer-to Peer Discussion
| 1 session | |
| Follow-up Peer-to Peer Discussion | Watch now |
About the episode
Lorem ipsum dolor sit amet, consectetur adipiscing elit. In interdum, lorem et suscipit efficitur, nulla arcu porta libero, eget dapibus augue turpis ut tellus. Fusce efficitur vel magna consequat porttitor. Vestibulum aliquam volutpat purus. Vivamus quis ligula scelerisque, malesuada felis sit amet, posuere risus. Nullam sapien elit, rutrum vitae dignissim vitae, rutrum sit amet magna. Fusce in cursus orci, consequat placerat purus. Vestibulum rhoncus iaculis imperdiet. Donec feugiat tincidunt viverra. Nam id rhoncus arcu. Maecenas bibendum imperdiet nunc vitae faucibus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Curabitur tellus libero, fermentum ut fermentum vel, placerat quis risus. Phasellus gravida quis neque eu ullamcorper.
Aenean porttitor viverra justo et tristique. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nullam ipsum elit, tempor eget maximus vitae, euismod a nisl. Nam placerat, leo nec feugiat malesuada, orci felis porta lectus, sit amet cursus velit tortor vel urna. Mauris vitae tortor in purus accumsan scelerisque. Maecenas sit amet commodo tellus. Aenean sit amet magna mauris. Nam imperdiet, ante in tincidunt posuere, elit velit pharetra arcu, et ornare ante ligula at felis. Curabitur vulputate pharetra est, sed aliquam nisi pretium nec. Sed vulputate ut odio at sodales. Aenean semper sem ut nisi placerat, ac elementum augue interdum. Donec ac arcu a lectus lacinia ultrices quis sed velit. Fusce vitae blandit ligula. Sed ut quam pellentesque, mollis dui vitae, ultrices risus. Quisque in lectus porttitor, pulvinar velit eu, rutrum lacus. Sed viverra interdum dapibus.
Faculty Biographies
Martin R Cowie
Dr Martin R Cowie is Professor of Cardiology at the National Heart and Lung Institute, Imperial College and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London.
Dr Cowie currently chairs the Clinical Practice Committee of the British Cardiac Society and sits on the UK Department of Health’s Primary Care and Heart Failure Implementation Board. He was the clinical advisor for the recently published National Institute for Clinical Excellence (NICE) guideline on the management of chronic heart failure and is a member of the Clinical Effectiveness Forum of the Royal College of Physicians. He has just completed a term of office on the Clinical Guidelines Committee of the European Society of Cardiology.
Dr Cowie’s studies and reviews have been featured in a variety of peer-reviewed journals, including The Lancet, European Heart Journal, British Medical Journal, Heart and the International Journal of Cardiology. He is a member of the…
